DE69725337D1 - 5-cyclo-indolverbindungen als 5-ht1d rezeptor liganden - Google Patents

5-cyclo-indolverbindungen als 5-ht1d rezeptor liganden

Info

Publication number
DE69725337D1
DE69725337D1 DE69725337T DE69725337T DE69725337D1 DE 69725337 D1 DE69725337 D1 DE 69725337D1 DE 69725337 T DE69725337 T DE 69725337T DE 69725337 T DE69725337 T DE 69725337T DE 69725337 D1 DE69725337 D1 DE 69725337D1
Authority
DE
Germany
Prior art keywords
loweralkyl
optionally substituted
ht1d
compounds
membered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69725337T
Other languages
English (en)
Other versions
DE69725337T2 (de
Inventor
Abdelmalik Slassi
Louise Edwards
Qingchang Meng
Sumanas Rakhit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NPS Allelix Corp Canada
Original Assignee
NPS Allelix Corp Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NPS Allelix Corp Canada filed Critical NPS Allelix Corp Canada
Application granted granted Critical
Publication of DE69725337D1 publication Critical patent/DE69725337D1/de
Publication of DE69725337T2 publication Critical patent/DE69725337T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Structures Or Materials For Encapsulating Or Coating Semiconductor Devices Or Solid State Devices (AREA)
  • Hybrid Cells (AREA)
DE69725337T 1996-11-26 1997-11-24 5-cyclo-indolverbindungen als 5-ht1d rezeptor liganden Expired - Fee Related DE69725337T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75580596A 1996-11-26 1996-11-26
US755805 1996-11-26
PCT/CA1997/000900 WO1998023587A1 (en) 1996-11-26 1997-11-24 5-cyclo indole compounds as 5-ht1d receptor ligands

Publications (2)

Publication Number Publication Date
DE69725337D1 true DE69725337D1 (de) 2003-11-06
DE69725337T2 DE69725337T2 (de) 2004-07-15

Family

ID=25040731

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69725337T Expired - Fee Related DE69725337T2 (de) 1996-11-26 1997-11-24 5-cyclo-indolverbindungen als 5-ht1d rezeptor liganden

Country Status (12)

Country Link
EP (1) EP0944595B1 (de)
JP (1) JP2001504501A (de)
CN (1) CN1289479C (de)
AT (1) ATE251136T1 (de)
AU (1) AU738668B2 (de)
CA (1) CA2273328C (de)
DE (1) DE69725337T2 (de)
ES (1) ES2208955T3 (de)
HK (1) HK1026689A1 (de)
TW (1) TW432059B (de)
WO (1) WO1998023587A1 (de)
ZA (1) ZA9710643B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100291A (en) * 1998-03-16 2000-08-08 Allelix Biopharmaceuticals Inc. Pyrrolidine-indole compounds having 5-HT6 affinity
US6251893B1 (en) * 1998-06-15 2001-06-26 Nps Allelix Corp. Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
US6329390B1 (en) * 1998-07-17 2001-12-11 Nps Allelix Corp. 5-Bicycloindole compounds
US6562809B1 (en) * 1998-09-18 2003-05-13 Nps Allelix Corp. 3-bicycloindole compounds
WO2000038677A1 (en) * 1998-12-23 2000-07-06 Allelix Biopharmaceuticals Inc. Indole and indolizidine derivatives for the treatment of migraine
DK1355904T3 (da) 2000-12-22 2007-10-15 Wyeth Corp Heterocyclindazol- og -azaindazolforbindelser som 5-hydroxytryptamin-6-ligander
EP1803720A1 (de) * 2000-12-22 2007-07-04 Wyeth a Corporation of the State of Delaware Hetorocyclindazole und -Azaindazole Verbindungen als 5-Hydroxytryptamine-6 Liganden
CA2515571A1 (en) 2003-02-14 2004-09-02 Wyeth Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
US8030257B2 (en) 2005-05-13 2011-10-04 Exxonmobil Research And Engineering Company Catalytic antioxidants
CN102936240A (zh) * 2012-10-30 2013-02-20 浙江省医学科学院 一种(r)-5-取代-3-(n-苄氧羰基吡咯烷-2-基羰基)-1h-吲哚的合成方法
CN107698558B (zh) * 2017-10-24 2019-04-02 温州大学 一种氮杂环硫化物的制备方法及其净化提纯方法
TW201938517A (zh) * 2017-12-01 2019-10-01 景凱生物科技股份有限公司 苯並雜環化合物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833153A (en) * 1985-11-08 1989-05-23 Glaxo Group Limited Indole derivatives
GB9226537D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5300645A (en) * 1993-04-14 1994-04-05 Eli Lilly And Company Tetrahydro-pyrido-indole
BR9406481A (pt) * 1993-04-22 1996-01-09 Pfizer Res & Dev Derivados de indol como agonistas do tipo 5-HT1 para utilização na enxaqueca

Also Published As

Publication number Publication date
CA2273328C (en) 2009-04-28
DE69725337T2 (de) 2004-07-15
ATE251136T1 (de) 2003-10-15
JP2001504501A (ja) 2001-04-03
EP0944595A1 (de) 1999-09-29
EP0944595B1 (de) 2003-10-01
HK1026689A1 (en) 2000-12-22
AU738668B2 (en) 2001-09-20
TW432059B (en) 2001-05-01
CA2273328A1 (en) 1998-06-04
WO1998023587A1 (en) 1998-06-04
ZA9710643B (en) 1998-09-02
ES2208955T3 (es) 2004-06-16
AU5112298A (en) 1998-06-22
CN1289479C (zh) 2006-12-13
CN1245491A (zh) 2000-02-23

Similar Documents

Publication Publication Date Title
DE69725337D1 (de) 5-cyclo-indolverbindungen als 5-ht1d rezeptor liganden
DE69025473D1 (de) Substituierte imidazole und ihre verwendung als hemmmstoff fur angiotensin ii
ATE103604T1 (de) Substituierte 5-((tetrazolyl)alkenyl>-imidazole.
BR0013427A (pt) Compostos heteropolicìclicos e seus usos como antagonistas no receptor de glutamato metabotrópico
DE59810922D1 (de) 4-heteroaryl-tetrahydrochinoline und ihre verwendung als inhibitoren des cholesterin-ester-transfer-proteins (ctep)
DK5389A (da) Substituerede pyrroler, pyrazoler og triazoler, fremgangsmaader til deres fremstilling samt deres anvendelse som angiotensin ii-antagonister
DE69433181D1 (de) 5-(2-imidazolinylamino)benzimidazol derivate, deren herstellung und deren verwendung als alpha-2-adrenoceptor agonisten
BR0114552A (pt) N1- (benzenosulfonil) indóis 2-,3-,4-, 5- substituìdos e seu uso em terapia
FI873631A (fi) --alkyl-4-amino-3-kinolinmetanoler och 1-(4-aralkylamino-3-kinolinyl)alkanoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
ATE12042T1 (de) Aminosaeurederivate und ihre therapeutische verwendung.
ES2173172T3 (es) Derivados de 1,3-dihidroindol-2-ona sustituidos en 3 por un grupo nitrogenado como agonistas y/o antagonistas de la vasopresina y/o de la octocina.
SE9103752D0 (sv) New compounds
ATE280164T1 (de) Benzothiadiazine als matrix metallproteinase inhibitoren
NO904799L (no) Substituerte n-(imidazolyl)alkylalanin-derivater.
ES2127789T3 (es) Derivados de 1,2,4-triazol 4-sustituidos.
PT1189923E (pt) Derivados aromaticos e heterociclicos de fitosterois e/ ou fitostanois para utilizacao no tratamento ou prevencao de doenca cardiovascular
ATE240321T1 (de) 4- (thien-3-yl)methyl) imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität
DE69819742D1 (de) Indolderivate als 5-ht1b und 5-ht1d agonisten
KR950002761A (ko) 강박 반응 장애 치료제 제조용으로서의 n-(피리디닐)-1h-인돌-1-아민의 용도
ATE234284T1 (de) Kondensierte isoindolone als proteinkinase c inhibitoren
ATE215365T1 (de) Medizinische verwendung von atypischen beta- adrenoceptor agonisten
SE9201076D0 (sv) The use of old drugs for the treatment of diabetes
ATE235450T1 (de) 2-indanmethanolderivate und ihre verwendung als riechstoffe
KR880008999A (ko) 3-아릴-5-알킬티오-4h-1,2,4-트리아졸
FI961793A0 (fi) Muistia parantavina aineina käyttökelpoiset 3-aryyli-4-alkyyli- ja 4,5-dialkyyli 4H-1,2,4-triatsolit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee